Dataset Information

Nanoparticle for delivery of antisense ?PNA oligomers targeting CCR5.

ABSTRACT: The development of a new class of peptide nucleic acids (PNAs), i.e., gamma PNAs (?PNAs), creates the need for a general and effective method for its delivery into cells for regulating gene expression in mammalian cells. Here we report the antisense activity of a recently developed hydrophilic and biocompatible diethylene glycol (miniPEG)-based gamma peptide nucleic acid called MP?PNAs via its delivery by poly(lactide-co-glycolide) (PLGA)-based nanoparticle system. We show that MP?PNA oligomers designed to bind to the selective region of chemokine receptor 5 (CC R5) transcript, induce potent and sequence-specific antisense effects as compared with regular PNA oligomers. In addition, PLGA nanoparticle delivery of MP?PNAs is not toxic to the cells. The findings reported in this study provide a combination of ?PNA technology and PLGA-based nanoparticle delivery method for regulating gene expression in live cells via the antisense mechanism.

SUBMITTER: Bahal R

PROVIDER: S-EPMC3771998 | biostudies-literature | 2013 Apr-Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Bahal Raman R McNeer Nicole Ali NA Ly Danith H DH Saltzman W Mark WM Glazer Peter M PM

Artificial DNA, PNA & XNA 20130401 2

The development of a new class of peptide nucleic acids (PNAs), i.e., gamma PNAs (γPNAs), creates the need for a general and effective method for its delivery into cells for regulating gene expression in mammalian cells. Here we report the antisense activity of a recently developed hydrophilic and biocompatible diethylene glycol (miniPEG)-based gamma peptide nucleic acid called MPγPNAs via its delivery by poly(lactide-co-glycolide) (PLGA)-based nanoparticle system. We show that MPγPNA oligomers ...[more]

PMID: 23954968

Similar Datasets

Project description:We have explored the merits of a novel delivery strategy for the antisense oligomers based on cell penetrating peptide (CPP) conjugated to a carrier PNA with sequence complementary to part of the antisense oligomer. The effect of these carrier CPP-PNAs was evaluated by using antisense PNA targeting splicing correction of the mutated luciferase gene in the HeLa pLuc705 cell line, reporting cellular (nuclear) uptake of the antisense PNA via luciferase activity measurement. Carrier CPP-PNA constructs were studied in terms of construct modification (with octaarginine and/or decanoic acid) and carrier PNA length (to adjust binding affinity). In general, the carrier CPP-PNA constructs including the ones with decanoyl modification provided significant increase of the activity of unmodified antisense PNA as well as of antisense octaarginine-PNA conjugates. Antisense activity, and by inference cellular delivery, of unmodified antisense PNA was enhanced at least 20-fold at 6 ?M upon the complexation with an equimolar amount of nonamer carrier decanoyl-CPP-PNA (Deca-cPNA1(9)-(D-Arg)8). The antisense activity of a CPP-PNA ((D-Arg)8-asPNA) (at 2 ?M) was improved 6-fold and 8-fold by a heptamer carrier CPP-PNA (cPNA1(7)-(D-Arg)8) and hexamer carrier decanoyl-CPP-PNA (Deca-cPNA1(6)-(D-Arg)8), respectively, without showing significant additional cellular toxicity. Most interestingly, the activity reached the same level obtained by enhancement with endosomolytic chloroquine (CQ) treatment, suggesting that the carrier might facilitate endosomal escape. Furthermore, 50% downregulation of luciferase expression at 60 nM siRNA was obtained using this carrier CPP-PNA delivery strategy (with CQ co-treatment) for a single stranded antisense RNA targeting normal luciferase mRNA. These results indicated that CPP-PNA carriers may be used as effective cellular delivery vectors for different types of antisense oligomers and also allows use of combinations of (at least two) different CPP ligands.

Dataset Information

Nanoparticle for delivery of antisense ?PNA oligomers targeting CCR5.

Publications

Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets